CE-Melphalan

Spectrum submits blood-cancer drug for FDA approval
Marketwatch
Fri, 12/26/14 - 09:52 am
Spectrum Pharmaceuticals
FDA
CE-Melphalan
Multiple Myeloma
Ligand Pharmaceuticals